Summary
Five male subjects with essential hypertension received chlorthalidone at each of four dose levels (25, 50, 100, and 200 mg/day) for eight week periods each preceded by an eight week placebo period. Dosage order was randomized and double-blind. During the last week of each active and placebo period an upright bicycle exercise study was carried out at three loads (100, 200, 300 kpm/min) for 6 min each. Oxygen consumption at the maximal workload was 42% of predicted at a heart rate of 170. During placebo therapy, increasing workloads were associated with a progressive increase in blood pressure, heart rate, and pressure-rate index (systolic pressure times heart rate). With increasing doses of chlorthalidone up to 100 mg/day, there was a progressive reduction in blood pressure and pressure-rate index. At 200 mg/day there were paradoxical increases in diastolic pressures, heart rates and pressure-rate indices above values observed at 100 mg/day. With increasing doses of chlorthalidone, there was a progressive increase in arterial blood CO2 content and pH. Increasing workloads were associated with increased arterial blood lactate and decreased arterial blood pH. The changes in lactate and pH were not different at the different dose levels. The best antihypertensive effect in these exercising subjects was observed at a daily dose of 100 mg of chlorthalidone. The exercise response was useful in the determination of potentially adverse hemodynamic consequences of the larger dose of chlorthalidone.
Similar content being viewed by others
References
Sanerstedt, R.: Hemodynamic findings at rest and during exercise in mild arterial hypertension. Amer. J. med. Sci.258 70–79 (1969)
Hughes, R., Clode, M., Edwards, R., Goodwin, T., Jones, N.: Effect of inspired O2 on cardiopulmonary and metabolic responses to exercise in man. J. appl. Physiol.24 336–347 (1968)
Scholander, P.F.: Analyzer for accurate estimation of respiratory gases in one half cubic centimeter samples. J. biol. Chem.167 235–250 (1947)
Hörn, H.D., Bruns, F.H.: Quantitative Bestimmung von L(+)-Milchsäure mit Milchsäuredehydrogenase. Biochim. biophys. Acta (Amst.)21 378–380 (1956)
Van Slyke, D.D., Neill, J.M.: Determination of gases in blood and other solutions by vacuum extraction and manometric measurement. J. biol. Chem.61 523–573 (1924)
Wahlund, H.: Determination of physical working capacity; physiological and clinical study with special reference to standardization of cardiopulmonary functional tests. Acta med. scan. (Suppl. 215)132 1–78 (1948)
Goldstein, A.: Biostatistics, an introductory text. New York: The Macmillan Co. 1964
Riley, R.L., Himmelstein, A., Motley, H.L.: Studies of the pulmonary circulation at rest, and during exercise in normal individuals and in patients with chronic pulmonary disease. Amer. J. Physiol.152 372–382 (1948)
McDonough, J., Kusumi, F., Bruce, F.: Variations in maximal oxygen intake with physical activity in midle-aged men. Circulation41 743–751 (1970)
Grimley, G., Häggendal, E., Saltin, B.: Local xenon 133 clearance from the quadriceps muscle during exercise in man. J. appl Physiol.22 305–310 (1967)
Hamer, J., Fleming, J., Shinebourne, E.: Effect of walking on blood pressure in systemic hypertension. Lancet1967 II 114–118
Johnson, W., Jones, J.: Hemodynamic and oxygen transport responses to exercise in hypertensive and normotensive age peers: effect of hypotensive drug treatments. Amer. J. med. Sci.253 180–192 (1967)
Hanson, J., Tabakin, B., Levy, A.: Comparative exercise-cardio-respiratory performance of normal men in the third, fourth and fifth decades of life. Circulation37 345–360 (1968)
Shineburne, E., Fleming, J., Hamer, J.: Effects of beta-adrenergic blockade during exercise in hypertensive and ischemic heart disease. Lancet1967 II 1217–1220
Johnsson, G., de Guzman, M., Bergman, H., Sannerstedt, R.: The hemodynamic effects of alprenolol and propranolol at rest and during exercise in hypertensive patients. Pharmacol. Clin.2 34–39 (1969)
Muir, A.L., Burton, J.L. and Lawrie, D.M.: Circulating effects at rest and exercise of clonidine, an imidazoline derivative with hypotensive properties. Lancet1969 II 181–185
Khatri, I.M., Cohn, J.N.: Mechanism of exercise hypotension after sympathetic blockade. Amer. J. Cardiol.25 239–338 (1970)
Kotchen, T., Hartley, L., Rice, T., Mougey E., Jones, L., Mason, J.: Renin, norepinephrine and epinephrine responses to graded exercise. J. appl. Physiol.31 178–184 (1971)
Åstrand, I.: Aerobic work capacity in men and women with special reference to age. Acta physiol. scand.49 (Suppl. 169), 1–92 (1960)
Faulkner, J., Roberts, D., Elk, R., Conway, J.: Cardiovascular responses to submaximum and maximum effort cycling and running. J. appl. Physiol.30 457–461 (1971)
Blomqvist, C.: Use of exercise testing for diagnostic and functional evaluation of patients with arteriosclerotic heart disease. Circulation44 1120–1136 (1971)
de Muckadell, O., Gyntelberg, F.: The anti-hypertensive effect of a new beta-blocking agent pindolol compared with chlorthalidone. Europ. J. clin. Pharmacol.5 210–213 (1973)
Ogilvie, R.I., Schlieper, E.: The effect of hydrochlorothiazide on venous reactivity in hypertensive man. Clin. Pharmacol. Ther.11 589–594 (1970)
Harris, P., Bateman, M., Bayley, T., Donald, K., Gloster, J., Whitehead, T.: Observations on the course of the metabolic events accompanying mild exercise. Quart. J. exp. Physiol.53 43–64 (1968)
Zborowska-Sluis, D., Dosseter, J.: Hyperlactatemia of hyperventilation. J. appl. Physiol.22 746–755 (1967)
Zborowska-Sluis, D., Ogilvie, R., Klassen, G.: Reversal of hyperventilation induced hyperlactatemia by acetazolamide. Resp. Physiol.11 127–134 (1970/71)
Tweeddale, M.G., Ogilvie, R.I.: Absorption and excretion of chlorthalidone in man. Clin. Res.20 913 (1972)
Tweeddale, M.G., Ogilvie, R.I.: Improved method for estimating chlorthalidone in body fluids. J. pharmaceut. Sci.63 1065–1068 (1974)
Author information
Authors and Affiliations
Additional information
Supported in part by grants from the Canadian Foundation for the Advancement of Therapeutics and the Joseph C. Edwards Foundation of Montreal
Rights and permissions
About this article
Cite this article
Ogilvie, R.I. Cardiovascular response to exercise under increasing doses of chlorthalidone. Eur J Clin Pharmacol 9, 339–344 (1976). https://doi.org/10.1007/BF00606546
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00606546